AI주식인사이트AI Stock Insight
B

안국약품

001540KOSDAQ의약품 제조업

65.8 / 100

Reference Date: 2026-06-10

Financial Score19.5 / 40
News Sentiment21.3 / 25
Momentum15.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE is above the industry average but the high debt ratio poses financial risk. Surged 33.9% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

AnKook Pharmaceuticals, established in 1959, is a company specializing in the production and sale of pharmaceuticals and health functional foods, with key products including Sinechura and Levotension. In 2022, sales increased by 16% year-on-year to 271.1 billion KRW, and operating profit rose 32.4% to 6.7 billion KRW, driven by strong market share in respiratory and circulatory drug segments. The company is expanding into AI medical devices and online sales through 'Ewonther' to diversify its business.

Number of Employees

424people

Average Salary

58.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
16.26Industry Average 11.933.0Point

Higher than industry avg (caution)

PBR
0.84Industry Average 0.894.0Point

In line with industry avg

ROE
4.42Industry Average 4.014.0Point

In line with industry avg

Debt Ratio
37.13Industry Average 12.430.0Point

3.0x industry avg (risky)

Trend 2023~20258.5 / 10 points
Revenue Growth Rate
2.5 / 3

Avg ▲14.6% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲39.5% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 5.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position8.0Point

Near 52w high (81%, uptrend)

Current 10,700Won52-week high 11,50052-week low 7,280
1-month return6.0Point

1m +33.92% (strong rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral주식등의대량보유상황보고서(일반)2026-06-05
  • Neutral생산재개(자율공시)2026-06-05
  • Neutral분기보고서 (2026.03)2026-05-14